GeneFirst Ltd - Product Pipeline Analysis, 2016 Update

Report code: GDME449854PD

Publisher: GlobalData

Formats: PDF

Published: June 29, 2016

Number of pages: 17

GeneFirst Ltd (GeneFirst) is a molecular diagnostics company that develops technologies and products in the fields of infectious disease, cancer diagnostics and personalized medicine. The company’s research products include MMD-PCR mutation detection kits, PCDR master mix, MPA-HPV test and PCDR-Dengue virus test. It offers multiplex mutation detection PCR Test Kit that include, GeneFirst Epidermal Growth Factor Receptor (EGFR), Kirsten rat sarcoma viral oncogene (KRAS), v-Raf murine sarcoma viral oncogene homolog B1 (BRAF), Janus kinase 2 (JAK2), phosphatidylinositol 3-kinase catalytic subunit (PIK3CA) and Abelson murine leukaemia viral oncogene homolog 1 (ABL). GeneFirst offers customised SNP genotyping, pathogen and mutation detection services. The company offers its products to researchers, clinicians and drug companies. GeneFirst is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GeneFirst Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

GeneFirst Ltd Company Snapshot 5

GeneFirst Ltd Company Overview 5

GeneFirst Ltd Pipeline Products and Clinical Trials Overview 5

GeneFirst Ltd – Pipeline Analysis Overview 7

Key Facts 7

GeneFirst Ltd - Major Products and Services 8

GeneFirst Ltd Pipeline Products by Development Stage 9

GeneFirst Ltd Pipeline Products Overview 11

GFscreen BRAF Mutation Detection Kit 11

GFscreen BRAF Mutation Detection Kit Product Overview 11

GFscreen EGFR Mutation Detection Kit 12

GFscreen EGFR Mutation Detection Kit Product Overview 12

GFscreen KRAS Mutation Detection Kit 13

GFscreen KRAS Mutation Detection Kit Product Overview 13

PCDR - Dengue Test 14

PCDR - Dengue Test Product Overview 14

GeneFirst Ltd - Key Competitors 15

GeneFirst Ltd - Key Employees 16

GeneFirst Ltd - Locations And Subsidiaries 17

Head Office 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18

List of Tables

List of Tables

GeneFirst Ltd Pipeline Products and Clinical Trials Overview 5

GeneFirst Ltd Pipeline Products by Equipment Type 6

GeneFirst Ltd Pipeline Products by Indication 6

GeneFirst Ltd, Key Facts 7

GeneFirst Ltd, Major Products and Services 8

GeneFirst Ltd Number of Pipeline Products by Development Stage 9

GeneFirst Ltd Pipeline Products Summary by Development Stage 10

GFscreen BRAF Mutation Detection Kit - Product Status 11

GFscreen BRAF Mutation Detection Kit - Product Description 11

GFscreen EGFR Mutation Detection Kit - Product Status 12

GFscreen EGFR Mutation Detection Kit - Product Description 12

GFscreen KRAS Mutation Detection Kit - Product Status 13

GFscreen KRAS Mutation Detection Kit - Product Description 13

PCDR - Dengue Test - Product Status 14

PCDR - Dengue Test - Product Description 14

GeneFirst Ltd, Key Employees 16

List of Figures

List of Figures

GeneFirst Ltd Pipeline Products by Equipment Type 6

GeneFirst Ltd Pipeline Products by Development Stage 9

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +44 161 359 5819.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP